This might seem contradictory to a large volume of epidemiology linking circulating total IGF‐I with increased risk of pre‐ and postmenopausal breast cancer, and circulating IGFBP‐3 and postmenopausal breast cancer 8. Here, IGF1 is linked to breast carcinoma.